Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Plos One|April 22, 2025
Assessing therapeutic decisions in generalized myasthenia gravis: Study protocolGerardo Gutiérrez-Gutiérrez, Rocío Gómez-Ballesteros, Javier Sotoca, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 21, 2021
Serum Contactin-1 in CIDP: A Cross-Sectional StudyLuuk Wieske, Lorena Martín-Aguilar, Janev Fehmi, et al.
Neurology and Therapy|September 19, 2025
Treatment Preferences of Neurologists in Generalized Myasthenia Gravis: A Conjoint Analysis StudyLuis Querol, Rocío Gómez-Ballesteros, Gerardo Gutiérrez-Gutiérrez, et al.
Neurology|February 28, 2020
Antibodies against nodo-paranodal proteins are not present in genetic neuropathiesLorena Martín-Aguilar, Elba Pascual-Goñi, Cinta Lleixà, et al.
Scientific Reports|April 18, 2019
Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathyElba Pascual-Goñi, Lorena Martín-Aguilar, Cinta Lleixà, et al.
Brain and Behavior|December 24, 2013
Endothelial progenitor cells in acute ischemic strokeJoan Martí-Fàbregas, Javier Crespo, Raquel Delgado-Mederos, et al.
Plos One|February 23, 2019
Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathyLena Duchateau, Lorena Martín-Aguilar, Cinta Lleixà, et al.
European Journal of Neurology|August 12, 2024
A nationwide Guillain-Barré syndrome epidemiological study in Spain during the COVID-19 yearsMarina Blanco-Ruiz, Lorena Martín-Aguilar, Marta Caballero-Ávila, et al.
Plos One|April 18, 2019
Correction: Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathyLena Duchateau, Lorena Martín-Aguilar, Cinta Lleixà, et al.
Pageof 13